N-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)-2-(1-phenyl-1H-tetrazol-5-ylthio)acetamide

ID: ALA4555143

Chembl Id: CHEMBL4555143

PubChem CID: 2125863

Max Phase: Preclinical

Molecular Formula: C22H23N7OS

Molecular Weight: 433.54

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)c1cc(NC(=O)CSc2nnnn2-c2ccccc2)n(-c2ccccc2)n1

Standard InChI:  InChI=1S/C22H23N7OS/c1-22(2,3)18-14-19(28(25-18)16-10-6-4-7-11-16)23-20(30)15-31-21-24-26-27-29(21)17-12-8-5-9-13-17/h4-14H,15H2,1-3H3,(H,23,30)

Standard InChI Key:  KZFPHKZQVCYHEZ-UHFFFAOYSA-N

Associated Targets(Human)

NTRK1 Tclin Nerve growth factor receptor Trk-A (7922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK2 Tclin Neurotrophic tyrosine kinase receptor type 2 (3279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFE2 Tchem Transcription factor NF-E2 45 kDa subunit (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ntrk1 Nerve growth factor receptor Trk-A (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 433.54Molecular Weight (Monoisotopic): 433.1685AlogP: 3.88#Rotatable Bonds: 6
Polar Surface Area: 90.52Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.55CX Basic pKa: 1.99CX LogP: 5.03CX LogD: 5.03
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.46Np Likeness Score: -2.51

References

1. Subramanian G, Bowen SJ, Zhu Y, Roush N, Zachary T, Javens C, Williams T, Janssen A, Gonzales A..  (2019)  Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA).,  29  (19): [PMID:31444087] [10.1016/j.bmcl.2019.126624]

Source